This article provides a comprehensive evaluation of the physiological relevance of tissues derived from human induced pluripotent stem cells (iPSCs) for biomedical research.
This article provides researchers and drug development professionals with a comprehensive analysis of how induced pluripotent stem cell (iPSC) models are addressing the critical translational gap in pharmaceutical research.
This article provides a comprehensive overview of the critical role of isogenic controls in induced pluripotent stem cell (iPSC)-based disease modeling.
The genomic integrity of induced pluripotent stem cells (iPSCs) is a paramount determinant of their safety and efficacy in disease modeling, drug discovery, and regenerative medicine.
This article provides a comprehensive overview of the strategies and challenges in validating disease phenotypes in induced pluripotent stem cell (iPSC) models against real-world clinical data.
This article provides a comprehensive comparative analysis of induced Pluripotent Stem Cells (iPSCs) and Embryonic Stem Cells (ESCs) for application in disease modeling and drug discovery.
This article provides a comprehensive analysis of induced pluripotent stem cell (iPSC)-derived neuronal models in comparison to traditional postmortem human brain tissue for neuroscience research and drug development.
This article provides a comprehensive comparison between two-dimensional (2D) monolayer and three-dimensional (3D) organoid models derived from induced pluripotent stem cells (iPSCs) for researchers and drug development professionals.
This article provides a systematic comparison of induced pluripotent stem cell (iPSC) models and traditional animal models for researching neurodegenerative diseases like Alzheimer's and Parkinson's.
This article provides a comprehensive guide for researchers and drug development professionals on the critical processes of cryopreserving and recovering induced pluripotent stem cell (iPSC) lines.